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INTRODUCTION
Ewingella americana is the only species of the genus of Ewi-
ngella in the family Enterobacteriaceae, first described from clin-
ical specimens in 1983 (1). The pathogenic significance and
niches of the reservoir have not been clarified. This organism
rarely causes human infections and has been identified from
various clinical specimens including wound, sputum, urine,
stool, blood (1, 2), conjunctiva (3) and peritoneal dialysate
(4). We present a chronic renal failure patient with fever and
haziness in right lung field on chest radiography. Since the
blood and urine cultures showed no other bacterial growth,
pneumonia caused by E. americana suspected to be the origin
of fever. Ceftriaxone and isepamicin (Yoohan, Seoul, Korea)
were administered and the clinical and radiological findings
were improved. As far as we know, this is the first report of
a pneumonia caused by E. americana. 
CASE REPORT
A 35-yr-old male who had undergone renal transplantation
was admitted to the University Hospital of Keimyung for
chronic rejection of the transplanted kidney on 1 May 2003.
He had chronic renal failure for 7 yr. On the day of admission,
peritoneal dialysis was initiated. After three days, he devel-
oped fever with right pleuritic chest pain. Physical examina-
tion revealed 38.2℃ of fever and pale conjunctiva with pit-
ting edema on both legs. Blood, urine and sputum samples
were obtained for culture. Laboratory findings were as follows:
white blood cells 9,770/ L (neutrophils 91%), hemoglobin
8.2 g/dL, hematocrit 24.3%, platelets 133,000/ L, blood urea
nitrogen 74 mg/dL, creatinine 7.3 mg/dL, fibrinogen/fibrin
degradation product (FDP) positive, fibrinogen 617 mg/dL
(reference range 200-400 mg/dL). The simple chest radiog-
raphy was performed and revealed haziness in right upper and
middle lung field.
He was empirically treated with ceftriaxone starting from
the very next day before the results of culture. Two days later,
isepamicin was added to the treatment regimen because of
persistent fever. Blood and urine culture did not show the
growth of any bacteria after 5 and 2 days, respectively. Gram
stain of sputum showed group 5 according to Washington-
Murray Grading as determining the quality of specimen (5).
Sputum culture revealed moderate growth of two-type colo-
nies, which were alpha-hemolytic streptococci and large gray-
ish colonies suspecting Gram-negative bacilli, on blood agar
plate after overnight incubation at 36℃. Lactose fermenting
Gram-negative bacilli were moderately grown on MacConkey
agar plate. Triple sugar iron agar showed A/K reaction for
this strain. The biochemical characteristics identified by the
VITEK GNI+ card (bioMerieux Vitek, Inc., Hazelwood, MO,
U.S.A.) are listed in Table 1. The antimicrobial susceptibility
test carried out by disk diffusion method showed susceptibili-
ties against amikacin, ampicillin, ampicillin-sulbactam, aztre-
onam, cefepime, cefoperazone-sulbactam, cefotaxime, cefox-
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A Case of Pneumonia Caused by Ewingella americana in a Patient
with Chronic Renal Failure 
Though the pathogenic significance and the reservoir of Ewingella americana have
not been clarified, this organism has caused several pathogenic infections, especially
in immunocompromised patients. We report a pneumonia in a patient with chronic
renal failure, who had chronic rejection of transplanted kidney. E. americana was
identified to be the pathogen of pneumonia with clinical symptoms and signs and
radiological examination. As soon as he was treated with ceftriaxone and isepam-
icin, clinical improvement was followed with no further growth of E. americana or other
pathogenic isolates from sputum culture. This suggests to be the case of pneumo-
nia caused by E. americana for the first time in the Korean literature.
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itin, ceftazidime, ciprofloxacin, gentamicin, imipenem, pipe-
racillin, piperacillin-tazobactam, and tetracycline, but only
resistant to cephalothin (Table 2).
On 12 May 2003, subsequent sputum culture failed to grow
either E. americana or any pathogenic bacteria. Chest radiogra-
phy findings were improved as the clinical signs and symp-
toms disappeared. Ceftriaxone and isepamicin were admin-
istered for an additional week. And he was discharged with
peroral medication of the antibiotics after the 15th day of
admission.
DISCUSSION
Clinical infections due to E. americana, a rare Gram-negative
bacilli with low pathogenic potential, have usually been in-
volved in immunocompromised patients and caused peritonitis
(4) and bacteremia (6, 7). Colonization in sputum (1), wound
(8), and pseudobacteremia (9, 10) were reported in patients
without clinical infections and in previously healthy patients.
Sputum was reported to be the most common source of iso-
lation (1, 2). Grimont reported that pneumonia or influenza
has been developed only in 2 cases out of 5 strains (1), and
Farmer et al. listed 14 sputum isolates without clinical reviews
(2). Therefore, the clinical significance of the isolate has not
been clear due to no further case studies. Bacteremia was the
most common infections of E. americana (6, 7, 11, 12). Very
recently, Tsokos reported a patient who died of Waterhouse-
Friderichen syndrome had growth of E. americana in heart and
spleen blood samples of postmortem bacteriologic cultures
and stated that the pathogenic potentiality of this strain (13).
Though several cases were published in the literature, little
is known about the natural habitat of organism. However,
McNeil proposed that the citrate solutions prepared in the
hospital for coagulations study may have constituted an inan-
imated environmental reservoir and resulted in recurrent pseu-
dobacteremia caused by E. americana (10). Also, the sources
of infection considered to be the domestic water in peritoni-
tis of a patient undergone peritoneal dialysis (4) and the con-
tamination of ice bath as a probable cause of bacteremia (12).
On the other hand, Maertens et al. speculated on the contam-
ination of catheter or inadequate hand hygiene as the source
of infection (11). E. americana can survive in water and grow
preferentially at 4℃ (10) and this isolate is not known to be
the normal flora of respiratory tract. Since this study did not
include evaluations dealing with water or other environmen-
tal sources throughout the admission, we could only presumed
that the general hygiene or water contamination might have
played a role in this infection.
According to the overall considerations of symptoms and
signs, laboratory findings and the clinical course following
antibiotics administration, we conclude that E. americana iso-
lated in sputum could be the pathogen of pneumonia in this
patient. Therefore we present the first case, to our knowledge,
of E. americana pneumonia in a chronic renal failure patient.
We have neither identified E. americana before in our laboratory
nor isolated since then from the specimens of other patients.
Regarding to the host and pathogenic potentiality, E. ameri-
Reactions Kati
� The pre-
sent strain
% of positive
reaction*
Indole production 0 not tested -
Citrate (Simmons) 95 + +
Hydrogen sulfide (TSI) 0 --
Urea hydrolysis 0 --
Lysine decarboxylase 0 --
Arginine dihydrolase 0 --
Ornithine decarboxylase 0 --
Motility (36℃)6 0 --
Malonate utilization 0 --
D-Glucose, acid 100 + +
D-Glucose, gas 0 --
Lactose fermentation 70 + +
Sucrose fermentation 0 --
D-Mannitol fermentation 100 + +
Adonitol fermentation 0 --
myo-Inositol fermentation 0 --
D-Sorbitol fermentation 0 --
L-Arabinose fermentation 0 --
Raffinose fermentation 0 --
L-Rhamnose fermentation 23 --
Maltose fermentation 16 + +
D-Xylose fermentation 13 - +
Esculin hydrolysis 50 + +
Acetate utilization 10 --
Nitrate reduction 97 not tested +
Oxidase, Kovacs 0 --
ONPG test 85 - +
Yellow pigmentation 0 --
Table 1. Biochemical characteristics of E. americana strains
*Reactions of the published strains (2), 
� Results from Kati et al. (4).
Antimicrobial agents
Interpretation
Kati* The present strain
Amikacin S S
Ampicillin S S
Ampicillin-sulbactam NT
� S
Aztreonam NT S
Cefepime S S
Cefotaxime S S
Cefoxitin NT S
Cephalothin R R
Ciprofloxacin (ofloxacin-Katti) S S
Gentamicin S S
Imipenem NT S
Piperacillin NT S
Piperacillin-tazobactam NT S
Tetracycline NT S
Table 2. Antimicrobial susceptibility results of E. americana
*Results from Kati et al. (4), 
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cana could become a rare but opportunistic pathogen of clin-
ical infections, especially in a immunocompromised person.
Even the etiology and route of infection have not been clearly
stated, this organism, E. americana, has finally resulted in pneu-
monia and treated well with immediate usage of antibiotics
in this patient. However, more cases and informations are
needed to clarify and postulate the ecology and pathogenici-
ty of E. americana in the hospital settings.
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